| Cardiac Structural Anomalies and Repair | Lifetime | 1 | US 1 | 99.98 |
| Cardiac Valve Diseases and Treatments | Lifetime | 5 | US 3 | 99.98 |
| Congenital Heart Disease Studies | Lifetime | 5 | US 3 | 99.89 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 6 | US 4 | 99.95 |
| Aortic Disease and Treatment Approaches | Lifetime | 6 | US 4 | 99.92 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 3 | US 2 | 99.92 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 33 | US 20 | 99.83 |
| Cardiomyopathy and Myosin Studies | Lifetime | 12 | US 8 | 99.85 |
| Pericarditis and Cardiac Tamponade | Lifetime | 3 | US 3 | 99.80 |
| Cardiovascular Function and Risk Factors | Lifetime | 77 | US 56 | 99.83 |
| Coronary Artery Anomalies | Lifetime | 19 | US 13 | 99.64 |
| Cardiac tumors and thrombi | Lifetime | 26 | US 14 | 99.68 |
| Cardiac Ischemia and Reperfusion | Lifetime | 55 | US 29 | 99.42 |
| Cardiovascular Effects of Exercise | Lifetime | 75 | US 38 | 99.44 |
| Mechanical Circulatory Support Devices | Lifetime | 141 | US 86 | 99.21 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 227 | US 96 | 99.36 |
| Cardiac Imaging and Diagnostics | Lifetime | 344 | US 185 | 99.42 |
| Cardiovascular Issues in Pregnancy | Lifetime | 94 | US 43 | 98.90 |
| Aortic aneurysm repair treatments | Lifetime | 176 | US 103 | 98.78 |
| Cardiac Arrhythmias and Treatments | Lifetime | 337 | US 172 | 99.05 |
| Vascular anomalies and interventions | Lifetime | 80 | US 57 | 98.64 |
| Myasthenia Gravis and Thymoma | Lifetime | 93 | US 29 | 98.29 |
| Coronary Interventions and Diagnostics | Lifetime | 312 | US 145 | 99.05 |
| Tracheal and airway disorders | Lifetime | 522 | US 288 | 98.28 |
| Cardiac Arrest and Resuscitation | Lifetime | 635 | US 344 | 98.33 |
| Nitric Oxide and Endothelin Effects | Lifetime | 451 | US 210 | 98.11 |
| Neuroendocrine Tumor Research Advances | Lifetime | 535 | US 226 | 98.20 |
| Cardiovascular and Diving-Related Complications | Lifetime | 177 | US 95 | 97.44 |
| Cardiac pacing and defibrillation studies | Lifetime | 568 | US 290 | 98.33 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 54 | US 16 | 96.71 |
| Neuroblastoma Research and Treatments | Lifetime | 466 | US 228 | 97.57 |
| Trauma Management and Diagnosis | Lifetime | 417 | US 257 | 96.71 |
| Blood transfusion and management | Lifetime | 301 | US 142 | 95.65 |
| Infectious Aortic and Vascular Conditions | Lifetime | 230 | US 117 | 96.40 |
| Vascular Tumors and Angiosarcomas | Lifetime | 812 | US 368 | 91.27 |
| Kawasaki Disease and Coronary Complications | Lifetime | 834 | US 210 | 86.80 |
| Vascular Anomalies and Treatments | Lifetime | 830 | US 296 | 83.80 |
| Williams Syndrome Research | Lifetime | 219 | US 96 | 81.37 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 24 | US 11 | 99.01 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 48 | US 22 | 99.15 |
| Congenital Heart Disease Studies | 2021-2025 | 44 | US 25 | 98.42 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 139 | US 63 | 99.00 |
| Cardiovascular Effects of Exercise | 2021-2025 | 63 | US 21 | 97.74 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 234 | US 103 | 98.16 |
| Cardiac and Coronary Surgery Techniques | 2021-2025 | 44 | US 19 | 95.08 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 247 | US 106 | 96.80 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 221 | US 100 | 95.92 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 32 | US 10 | 92.77 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 854 | US 295 | 93.53 |
| Viral Infections and Immunology Research | 2021-2025 | 295 | US 82 | 90.79 |
| Coronary Artery Anomalies | 2021-2025 | 213 | US 74 | 85.90 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 625 | US 229 | 79.54 |
| Vascular anomalies and interventions | 2021-2025 | 563 | US 180 | 61.10 |
